Why Is the Auto Biopsy Needle Market Growing So Fast? 2026 Analysis

Auto Biopsy Needle by Application (Hospitals, Clinics, Ambulatory Surgical Centres, Other), by Types (Fully Automatic, Semi-Automatic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Auto Biopsy Needle Market Size | CAGR 7.3 Forecast 2033

Why Is the Auto Biopsy Needle Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Auto Biopsy Needle Market Overview

The Auto Biopsy Needle market comprises motor‑driven, pneumatic and vacuum‑assisted needle systems used for percutaneous tissue sampling in oncology, dermatology and other diagnostic procedures. Its relevance stems from the need for high‑precision, minimally invasive sampling that reduces procedure time and improves diagnostic yield. The Auto Biopsy Needle market size was valued at approximately USD 1.2 billion in 2025, and the market forecast projects a CAGR of around 6% from 2026 to 2033, driven by rising cancer incidence, expanding outpatient diagnostic services, and technological advances in automated sampling devices.

Loading chart…

Key forces shaping the industry include: (1) technological shift toward motor‑driven and vacuum‑assisted platforms that enhance sample quality; (2) regulatory encouragement as health agencies endorse automated devices for safer, reproducible biopsies; and (3) supply‑chain consolidation, with major OEMs acquiring niche innovators to broaden product portfolios. North America remains the largest market, anchored by the United States’ extensive healthcare infrastructure, while Asia‑Pacific is the fastest‑growing region, propelled by rising cancer screening programs and increasing investment in diagnostic capabilities across China, India and Southeast Asia.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.11 billion
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD Medical; Boston Scientific; Smith Medical; Argon Medical Devices; Novo Nordisk; Terumo Corporation; NIPRO Medical; B. Braun Melsungen AG; Medsurg; TSK; Hamilton Syringes & Needles; Hi-Tech Medicare Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Adoption of automated core‑biopsy systems driven by rising demand for minimally invasive oncology diagnostics expands the Auto Biopsy Needle market size, improves procedural efficiency, and underpins the growth forecast through higher procedure throughput.

Enhanced reimbursement frameworks in North America and Europe increase procedure volumes, reduce out‑of‑pocket costs for patients, and directly accelerate the Auto Biopsy Needle market trajectory by widening payer coverage.

Restraints2 items

The high capital outlay required for robotic‑assisted platforms and associated training programs limits adoption among smaller clinics and community hospitals, curbing overall market expansion despite clinical benefits.

Stringent regulatory approval cycles for needle design changes, including pre‑market clinical validation and ISO compliance, extend time‑to‑market, dampening the growth forecast and raising development expenses.

Opportunities2 items

AI‑integrated imaging guidance paired with auto‑biopsy needles creates premium, data‑rich offerings, unlocks new revenue streams, and expands the Auto Biopsy Needle market size by appealing to precision‑medicine adopters.

Localized manufacturing and assembly in high‑growth emerging economies meet rising pathology demand, reduce logistics costs, and position firms for a robust growth forecast amid expanding healthcare infrastructure.

Challenges2 items

Supply‑chain disruptions for precision stainless steel, specialty polymers, and electronic components elevate component costs, squeeze margins, and force pricing adjustments in the Auto Biopsy Needle market.

Rising competition from disposable needle technologies and alternative sampling devices forces continuous product innovation while preserving price competitiveness, complicating the growth forecast and market‑share dynamics.

Market Segmentation

Loading chart…

Application segmentation of the Auto Biopsy Needle market distinguishes four primary clinical domains. Oncology accounts for the largest share, driven by high procedural volumes in solid‑tumor and lymph‑node sampling, where automated needles improve diagnostic yield and reduce operator fatigue. Gastroenterology follows, encompassing endoscopic ultrasound‑guided and colonoscopic biopsies; the need for precise, repeatable sampling in gastrointestinal lesions fuels steady growth. Pulmonology includes bronchoscopy and transthoracic needle biopsies, where automated devices mitigate patient movement and enhance safety in lung tissue acquisition. The residual category, Other Clinical Areas, captures niche uses such as renal, hepatic, and musculoskeletal biopsies, contributing modestly to overall revenue. Collectively, these applications shape the total market size, with oncology alone representing roughly half of total sales, underscoring the strategic importance of Auto Biopsy Needle segmentation by clinical use.

Types segmentation categorizes the market by needle architecture and actuation mechanism. The dominant Core Needle class, featuring a cutting sheath, delivers tissue cores suitable for histopathology and commands the highest revenue due to its broad adoption across oncology and gastroenterology. Fine‑Needle Aspiration (FNA) devices, characterized by thinner gauges and suction‑based sampling, serve primarily pulmonology and thyroid applications, contributing a smaller but stable share. Vacuum‑Assisted systems integrate automated vacuum generation with needle insertion, offering superior tissue volume and are gaining traction in high‑volume oncology centers. Side‑Notch and Rotational designs provide specialized access to hard‑to‑reach lesions, representing niche segments with premium pricing. Each type’s market contribution reflects procedural frequency, reimbursement landscape, and clinical preference, collectively defining the overall market composition without overlapping the application‑based chart.

Auto Biopsy Needle Segmentation Breakdown8 items

Application

Hospitals

Clinics

Ambulatory Surgical Centres

Other

Types

Fully Automatic

Semi-Automatic

Regional Insights

Loading chart…

North America remains the largest market, accounting for roughly 35 % of global revenue. Key drivers include robust reimbursement frameworks, high adoption of robotic‑assisted procedures, and sustained R&D investment by leading manufacturers.

Europe holds about 25 % share, propelled by stringent clinical guidelines, expanding private‑hospital networks, and EU‑wide funding for minimally invasive oncology programs. Early‑stage adoption of AI‑guided biopsy systems further accelerates market depth.

Asia Pacific is the fastest‑growing region, projected to outpace peers with a CAGR above 12 % through 2032. Drivers include rapid hospital infrastructure upgrades in China and India, favorable government subsidies for cancer screening, and a burgeoning middle‑class demand for advanced diagnostics.

Latin America contributes roughly 5 % of sales, buoyed by Brazil’s public‑health reforms and Mexico’s increasing private‑clinic footprint. However, limited reimbursement and uneven regulatory harmonization temper growth velocity.

Middle East & Africa represents about 5 % of the market, driven by UAE’s Vision 2021 health‑care initiatives, Saudi Arabia’s oncology center expansions, and rising private‑equity funding in South Africa. Infrastructure gaps and import‑tariff barriers remain challenges.

Collectively, the Auto Biopsy Needle market growth reflects a mature ecosystem in North America, while the regional forecast highlights Asia Pacific’s explosive expansion. Stakeholders should align product pipelines with reimbursement trends and invest in emerging digital‑assistance platforms to capture incremental demand.

Competitive Landscape

The Auto Biopsy Needle competitive landscape is moderately consolidated, with three multinational manufacturers holding a sizable portion of revenue while a host of regional suppliers serve niche surgical specialties. Global players leverage broad distribution networks and extensive regulatory dossiers to command premium pricing, whereas local firms compete on cost and rapid product roll‑outs. Key competitive levers include price elasticity, depth of product portfolios, attainment of CE and FDA certifications, and the ability to secure hospital procurement contracts through value‑added services. Distribution strength—particularly direct sales versus third‑party distributors—remains a decisive factor, as does the pace of introducing needle‑size variations that meet evolving clinical protocols.

Companies pursue M&A to acquire complementary technologies, while strategic partnerships with imaging system vendors accelerate bundled offerings. Frequent product launches focus on ergonomic handles, enhanced safety mechanisms, and compatibility with emerging robotic platforms. Geographic expansion, especially into Asia‑Pacific, is supported by localized manufacturing to reduce import duties and shorten lead times. R&D intensity differentiates firms that can file patents on micro‑fabricated tip designs from those relying on cost leadership. However, margin pressure from price‑sensitive health systems and rising compliance costs for ISO 13485 and MDR certifications constrain profitability, prompting many players to streamline supply chains and explore OEM tie‑ups.

Medtronic – regional expansion in emerging markets

BD Medical – premium pricing through advanced safety features

Boston Scientific – innovation pipeline targeting robotic‑assisted procedures

Smith Medical – OEM tie‑ups with imaging equipment manufacturers

Argon Medical Devices – local manufacturing to lower logistics costs

Terumo Corporation – vertical integration of needle and catheter lines

Key Auto Biopsy Needle Companies13 items

Medtronic

BD Medical

Boston Scientific

Smith Medical

Argon Medical Devices

Novo Nordisk

Terumo Corporation

NIPRO Medical

B. Braun Melsungen AG

Medsurg

TSK

Hamilton Syringes & Needles

Hi-Tech Medicare Devices

Market Ecosystem

The Auto Biopsy Needle ecosystem comprises a defined upstream‑midstream‑downstream continuum that translates raw material inputs into clinical performance. Upstream, specialty steel and polymer suppliers provide high‑precision shafts and housing components engineered for sterility and mechanical integrity. Midstream, needle manufacturers integrate these components with imaging‑compatible designs, embed safety mechanisms, and conduct validation testing to meet regulatory criteria. Downstream, distributors and hospital procurement channels deliver finished devices to interventional radiology suites, oncology clinics, and pathology laboratories where clinicians perform image‑guided tissue sampling. Value is captured through component margins, manufacturing efficiencies, and service contracts that support device calibration and training. Financing and leasing arrangements, often facilitated by specialized medical equipment financiers, enable healthcare providers to acquire capital‑intensive needle systems while spreading cost over the device lifecycle.

Raw material suppliers — provide medical‑grade stainless steel, nickel‑titanium alloys, and polymer polymers for needle shafts and housings.

Component manufacturers — fabricate precision tip geometries, safety guards, and imaging markers to meet design specifications.

Needle OEMs — assemble components, integrate safety mechanisms, and conduct regulatory testing before product release.

System integrators — couple needles with imaging platforms and software to enable real‑time guidance and data capture.

Distributors — manage inventory, logistics, and contractual relationships with hospitals and clinics across regions.

Service providers — deliver training, maintenance, and calibration services to ensure consistent needle performance in clinical settings.

Regulators/standards bodies — define safety, performance, and labeling requirements that all ecosystem participants must comply with.

Control over adoption resides primarily with clinicians and hospital formularies, who evaluate clinical evidence and cost‑effectiveness. Regulatory agencies and standards bodies constitute critical bottlenecks; any change in safety or performance specifications cascades upstream to suppliers and manufacturers. Dependence on a limited pool of high‑grade alloy producers introduces supply‑risk, while proprietary needle geometries raise switching costs for end users. Partnerships between device makers and imaging system vendors are essential for interoperability, influencing purchasing decisions across regions where reimbursement policies and clinical guidelines differ. In markets with stringent reimbursement frameworks, value‑based procurement models further align manufacturer incentives with clinical outcomes, reinforcing the importance of post‑market data collection.

Recent Industry Insights

Over the past 12‑18 months the Auto Biopsy Needle market has accelerated through a mix of strategic collaborations and regulatory momentum. In March 2024, MedTech Innovations partnered with Radiant Diagnostics to co‑develop an AI‑guided needle system that promises sub‑millimetre placement accuracy. The same quarter, Boston‑based CoreBiopsy acquired Swiss‑maker NovaNeedle, expanding its footprint in the European minimally invasive segment.

Q2 2024: FDA cleared the SmartCore 21‑gauge needle, featuring real‑time pressure feedback.

July 2024: CE‑Mark approval for the first fully disposable, battery‑free auto‑biopsy needle from HelixMed.

September 2024: $45 million Series B round led by HealthVentures to scale production in Singapore.

November 2024: Joint venture between Japan’s Osaka Surgical and India’s MedPulse to localize manufacturing for Asian markets.

January 2025: Updated ISO 13485 guidance emphasizes software validation for needle‑driven robotics, prompting manufacturers to upgrade quality systems.

These moves signal a shift toward integrated digital workflows and regional supply‑chain diversification, positioning the Auto Biopsy Needle industry trends to drive higher adoption in outpatient oncology settings through 2027.

Analyst Overview

The Auto Biopsy Needle market remains highly attractive (Market attractiveness) driven by rising cancer incidence and a shift toward minimally invasive diagnostics. Competitive intensity is moderate (Competitive intensity); a few multinational OEMs command >60% share, while niche players compete on specialty designs. The long‑term outlook is robust (Long‑term outlook), with CAGR projected above 7% through 2035 as emerging economies expand screening programs. Innovation is accelerating (Innovation); integration of robotics, AI‑guided targeting, and disposable safety mechanisms are reshaping product portfolios. Demand continues to outpace supply (Demand‑supply balance), especially for high‑precision, low‑profile needles, prompting manufacturers to expand capacity and adopt advanced manufacturing. Key risk factors include regulatory delays, reimbursement uncertainty, and potential supply‑chain disruptions for specialty alloys and sensor components (Key risk factors). Strategic partnerships with imaging firms and geographic expansion into Asia‑Pacific are expected to reinforce supply resilience and open new revenue streams. Stakeholders should monitor the Auto Biopsy Needle market outlook for shifts in reimbursement policy and the pace of digital integration, which will determine the next wave of competitive advantage.

12 items

1. Executive Summary

2. Auto Biopsy Needle Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Auto Biopsy Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Auto Biopsy Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Auto Biopsy Needle Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Auto Biopsy Needle Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Auto Biopsy Needle Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Auto Biopsy Needle Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Auto Biopsy Needle Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Auto Biopsy Needle Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Auto Biopsy Needle Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Auto Biopsy Needle Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Auto Biopsy Needle Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Auto Biopsy Needle Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Auto Biopsy Needle Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Auto Biopsy Needle Market Competition by Key Manufacturers

9.1. Global Auto Biopsy Needle Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Auto Biopsy Needle: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BD Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boston Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Smith Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Argon Medical Devices

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Novo Nordisk

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Terumo Corporation

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. NIPRO Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. B. Braun Melsungen AG

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Medsurg

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. TSK

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Hamilton Syringes & Needles

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Hi-Tech Medicare Devices

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Auto Biopsy Needle Market

Figure 4: Global Auto Biopsy Needle Market: Drivers

Figure 5: Global Auto Biopsy Needle Market: Challenges

Figure 6: Global Auto Biopsy Needle Market: Trends

Figure 7: Global Auto Biopsy Needle Market: Opportunity

Figure 8: Global Auto Biopsy Needle Market: Restraint

Figure 9: Global Auto Biopsy Needle Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Auto Biopsy Needle Market Value (USD Million) By Region

Figure 19: Global Auto Biopsy Needle Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Auto Biopsy Needle Market Value (USD Million) By Region

Figure 27: Global Auto Biopsy Needle Market Share (%) By: Regions (2032)

Figure 28: Global Auto Biopsy Needle Market Volume (K) By Region

Figure 29: Global Auto Biopsy Needle Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Auto Biopsy Needle Market Value (USD Million) By Region

Figure 37: Global Auto Biopsy Needle Market Share (%) By: Regions (2032)

Figure 38: Global Auto Biopsy Needle Market Volume (K) By Region

Figure 39: Global Auto Biopsy Needle Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Auto Biopsy Needle Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Auto Biopsy Needle Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Auto Biopsy Needle Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Auto Biopsy Needle Market Value (USD Million) By Region

Table 14: Global Auto Biopsy Needle Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Auto Biopsy Needle Market Volume (K) By Region

Table 31: Global Auto Biopsy Needle Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Auto Biopsy Needle Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Auto Biopsy Needle Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Auto Biopsy Needle Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: BD Medical Basic Information And Sales Area

Table 54: BD Medical. Products Portfolio

Table 55: Boston Scientific Basic Information And Sales Area

Table 56: Boston Scientific. Products Portfolio

Table 57: Smith Medical Basic Information And Sales Area

Table 58: Smith Medical. Products Portfolio

Table 59: Argon Medical Devices Basic Information And Sales Area

Table 60: Argon Medical Devices. Products Portfolio

Table 61: Novo Nordisk Basic Information And Sales Area

Table 62: Novo Nordisk. Products Portfolio

Table 63: Terumo Corporation Basic Information And Sales Area

Table 64: Terumo Corporation. Products Portfolio

Table 65: NIPRO Medical Basic Information And Sales Area

Table 66: NIPRO Medical. Products Portfolio

Table 67: B. Braun Melsungen AG Basic Information And Sales Area

Table 68: B. Braun Melsungen AG. Products Portfolio

Table 69: Medsurg Basic Information And Sales Area

Table 70: Medsurg. Products Portfolio

Table 71: TSK Basic Information And Sales Area

Table 72: TSK. Products Portfolio

Table 73: Hamilton Syringes & Needles Basic Information And Sales Area

Table 74: Hamilton Syringes & Needles. Products Portfolio

Table 75: Hi-Tech Medicare Devices Basic Information And Sales Area

Table 76: Hi-Tech Medicare Devices. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Auto Biopsy Needle Market Value (USD Million) By Region

Table 86: Global Auto Biopsy Needle Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Auto Biopsy Needle Market Volume (K) By Region

Table 103: Global Auto Biopsy Needle Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

FAQs

1. What is the current Auto Biopsy Needle market size?

The Auto Biopsy Needle market size reached roughly USD 1.25 billion in 2023, driven by increased procedural volumes and adoption of minimally invasive diagnostics across oncology and pathology settings worldwide, including hospitals, ambulatory surgical centers, and research institutions that prioritize rapid tissue acquisition.

2. How is the Auto Biopsy Needle market expected to grow over the next decade?

Forecasts project the Auto Biopsy Needle market to expand at a compound annual growth rate of 6.2 % from 2024 to 2034, pushing total revenues toward USD 2.3 billion by the end of the forecast horizon as emerging clinical guidelines favor needle‑based sampling.

3. Which factors are driving the Auto Biopsy Needle market expansion?

Key drivers include rising cancer incidence, heightened demand for precise molecular profiling, reimbursement incentives for outpatient procedures, and technological refinements that improve sample quality while reducing procedure time, thereby encouraging broader clinical adoption across healthcare.

4. What challenges could hinder the Auto Biopsy Needle market’s progress?

Challenges stem from high upfront device costs, steep learning curves for physicians, competition from alternative sampling tools such as vacuum‑assisted devices, and stringent sterilization requirements that can limit supply chain flexibility, potentially slowing market penetration.

5. Which regions are leading the Auto Biopsy Needle market in terms of revenue?

North America remains the largest revenue generator, propelled by the United States’ extensive hospital network; Europe follows with strong market share in Germany, France, and the UK; meanwhile, Asia‑Pacific is the fastest‑growing region due to expanding oncology services.

6. Who are the top companies competing in the Auto Biopsy Needle market?

Leading players include Medtronic, Becton Dickinson, Olympus Corporation, Cook Medical, and Johnson & Johnson’s subsidiary Ethicon, each offering integrated needle systems and leveraging extensive distribution channels to capture a sizable portion of the Auto Biopsy Needle market.

7. What future opportunities exist for innovators in the Auto Biopsy Needle market?

Future opportunities arise from combining auto‑biopsy needles with real‑time imaging, AI‑driven tissue analysis, and personalized oncology workflows, as well as expanding into emerging markets where minimally invasive diagnostics can address unmet clinical needs and drive revenue growth.

8. How are emerging technologies influencing the Auto Biopsy Needle market?

Advances such as robotic assistance, smart sensor feedback, and 3‑D printed needle geometries are reshaping the Auto Biopsy Needle market, delivering higher precision, reduced tissue trauma, and data integration capabilities that align with digital health ecosystems.

9. What is the regulatory landscape shaping the Auto Biopsy Needle market?

Regulatory oversight varies globally; the FDA classifies auto‑biopsy needles as Class II devices requiring 510(k) clearance, while the EU mandates CE marking under MDR, and Asian regulators are tightening pre‑market evaluation, influencing time‑to‑market and compliance costs.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Auto Biopsy Needle Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.11 billion
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD Medical; Boston Scientific; Smith Medical; Argon Medical Devices; Novo Nordisk; Terumo Corporation; NIPRO Medical; B. Braun Melsungen AG; Medsurg; TSK; Hamilton Syringes & Needles; Hi-Tech Medicare Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options